Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets

Arthritis Research and Therapy

Volumn 10, Issue 2, 2008, Pages

  van der Helm van Mil, Annette H M ^a   Huizinga, Tom W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C5; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; FC RECEPTOR LIKE PROTEIN 3; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; PEPTIDYLARGININE DEIMINASE 4; PROTEIN ARGININE DEIMINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22; STAT4 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3 OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG; AUTOANTIBODY; AUTOANTIGEN; CITRULLINE;

ALLELE; BONE DESTRUCTION; CARTILAGE DEGENERATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; ANIMAL; CLASSIFICATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CITRULLINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 52149095213     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2384     Document Type: Review

References (55)

1. Harrison BJ Symmons DP Barrett EM Silman AJ The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association J Rheumatol 1998, 25:2324-2330. 9858425
2. Harrison B Symmons D Early inflammatory polyarthritis: Results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years Rheumatology (Oxford) 2000, 39:939-949. 10.1093/ rheumatology/39.9.939 10986297
3. Symmons DP Hazes JM Silman AJ Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis J Rheumatol 2003, 30:902-904. 12734878
4. Green M Marzo-Ortega H McGonagle D Wakefield R Proud-man S Conaghan P Gooi J Emery P Persistence of mild, early inflammatory arthritis: The importance of disease duration, rheumatoid factor, and the shared epitope Arthritis Rheum 1999, 42:2184-2188. 10.1002/ 1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO;2-2 10524691
5. Machold KP Stamm TA Eberl GJ Nell VK Dunky A Uffmann M Smolen JS Very recent onset arthritis - clinical, laboratory, and radiological findings during the first year of disease J Rheumatol 2002, 29:2278-2287. 12415582
6. van der Heijde DM van Leeuwen MA van Riel PL van de Putte LB Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification) J Rheumatol 1995, 22:1792-1796. 8523365
7. Nell VP Machold KP Stamm TA Eberl G Heinzl H Uffmann M Smolen JS Steiner G Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis Ann Rheum Dis 2005, 64:1731-1736. 10.1136/ ard.2005.035691 15878904
8. Gregersen PK Silver J Winchester RJ The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum 1987, 30:1205-1213. 10.1002/ art.1780301102 2446635
9. MacGregor AJ Antoniades L Matson M Andrew T Spector TD Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins Arthritis Rheum 2000, 43:30-37. 10.1002/ 1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B 10643697
10. Deighton CM Walker DJ Griffiths ID Roberts DF The contribution of HLA to rheumatoid arthritis Clin Genet 1989, 36:178-182. 2676268
11. Huizinga TW Amos CI van der Helm-van Mil AH Chen W van Gaalen FA Jawaheer D Schreuder GM Wener M Breedveld FC Ahmad N Lum RF de Vries RR Gregersen PK Toes RE Criswell LA Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins Arthritis Rheum 2005, 52:3433-3438. 10.1002/art.21385 16255021
12. Irigoyen P Lee AT Wener MH Li W Kern M Batliwalla F Lum RF Massarotti E Weisman M Bombardier C Remmers EF Kastner DL Seldin MF Criswell LA Gregersen PK Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA-DR3 and the shared epitope alleles Arthritis Rheum 2005, 52:3813-3818. 10.1002/art.21419 16320316
13. van der Helm-van Mil AH Verpoort KN Breedveld FC Huizinga TW Toes ER de Vries RR The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-CCP antibodies and are not an independent risk factor to develop RA Arthritis Rheum 2006, 54:1117-1121. 10.1002/art.21739 16572446
14. Begovich AB Carlton VE Honigberg LA Schrodi SJ Chokkalingam AP Alexander HC Ardlie KG Huang Q Smith AM Spoerke JM Conn MT Chang M Chang SY Saiki RK Catanese JJ Leong DU Garcia VE McAllister LB Jeffery DA Lee AT Batli-walla F Remmers E Criswell LA Seldin MF Kastner DL Amos CI Sninsky JJ Gregersen PK A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phos-phatase (PTPN22) is associated with rheumatoid arthritis Am J Hum Genet 2004, 75:330-337. 1216068 15208781 10.1086/422827
15. van Oene M Wintle RF Liu X Yazdanpanah M Gu X Newman B Kwan A Johnson B Owen J Greer W Mosher D Maksymowych W Keystone E Rubin LA Amos CI Siminovitch KA Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations Arthritis Rheum 2005, 52:1993-1998. 10.1002/art.21123 15986374
16. Gomez LM Anaya JM Gonzalez CI Pineda-Tamayo R Otero W Arango A Martin J PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases Genes Immun 2005, 6:628-631. 10.1038/sj.gene.6364261 16163373
17. Wesoly J van der Helm-van Mil AH Toes RE Chokkalingam AP Carlton VE Begovich AB Huizinga TW Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort Arthritis Rheum 2005. 52:2948-2950. 10.1002/ art.21294 16145680
18. Kallberg H Padyukov L Plenge RM Ronnelid J Gregersen PK van der Helm-van Mil AH Toes RE Huizinga TW Klareskog L Alfredsson L Epidemiological Investigation of Rheumatoid Arthritis study group Gene-gene and gene-environment interactions involving HLA-DR, PTPN22 and smoking in two subsets of rheumatoid arthritis Am J Hum Genet 2007, 80:867-875. 1852748 17436241 10.1086/516736
19. Hasegawa K Martin F Huang G Tumas D Diehl L Chan AC PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells Science 2004, 303:685-689. 10.1126/science.1092138 14752163
20. Vang T Congia M Macis MD Musumeci L Orrú V Zavattari P Nika K Tautz L Taskén K Cucca F Mustelin T Bottini N Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant Nat Genet 2005, 37:1317-1319. 10.1038/ng1673 16273109
21. Kurreeman FA Padyukov L Marques RB Schrodi SJ Sed-dighzadeh M Stoeken-Rijsbergen G van der Helm-van Mil AH Allaart CF Verduyn W Houwing-Duistermaat J Alfredsson L Begovich AB Klareskog L Huizinga TW Toes RE A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis PLoS Med 2007, 4:e278. 1976626 17880261 10.1371/journal.pmed.0040278
22. Wang Y Kristan J Hao L Lenkoski CS Shen Y Matis LA A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis J Immunol 2000, 164:4340-4347. 10754334
23. Wang Y Rollins SA Madri JA Matis LA Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease Proc Natl Acad Sci USA 1995, 92:8955-8959. 41086 7568051 10.1073/ pnas.92.19.8955
24. Grant EP Picarella D Burwell T Delaney T Croci A Avitahl N Humbles AA Gutierrez-Ramos JC Briskin M Gerard C Coyle AJ Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis J Exp Med 2002, 196:1461-1471. 10.1084/jem.20020205 12461081
25. Høgåsen K Mollnes TE Harboe M Götze O Hammer HB Oppermann M Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid J Rheumatol 1995, 22:24-28. 7535360
26. Plenge RM Seielstad M Padyukov L Lee AT Remmers EF Ding B Liew A Khalili H Chandrasekaran A Davies LR Li W Tan AK Bonnard C Ong RT Thalamuthu A Pettersson S Liu C Tian C Chen WV Carulli JP Beckman EM Altshuler D Alfredsson L Criswell LA Amos CI Seldin MF Kastner DL Klareskog L Gregersen PK TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study N Engl J Med 2007, 357:1199-1209. 10.1056/NEJMoa073491 17804836
27. Rodriguez MR Nunez-Roldan A Aguilar F Valenzuela A Garcia A Gonzalez-Escribano MF Association of the CTLA4 3′ untranslated region polymorphism with the susceptibility to rheumatoid arthritis Hum Immunol 2002, 63:76-81. 10.1016/S0198-8859(01)00358-5 11916172
28. Vaidya B Pearce SH Charlton S Marshall N Rowan AD Griffiths ID Kendall-Taylor P Cawston TE Young-Min S An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies Rheumatology (Oxford) 2002, 41:180-183. 10.1093/ rheumatology/41.2.180 11886967
29. Plenge RM Padyukov L Remmers EF Purcell S Lee AT Karlson EW Wolfe F Kastner DL Alfredsson L Altshuler D Gregersen PK Klareskog L Rioux JD Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 Am J Hum Genet 2005, 77:1044-1060. 1285162 16380915 10.1086/498651
30. Remmers EF Plenge RM Lee AT Graham RR Hom G Behrens TW de Bakker PI Le JM Lee HS Batliwalla F Li W Masters SL Booty MG Carulli JP Padyukov L Alfredsson L Klareskog L Chen WV Amos CI Criswell LA Seldin MF Kastner DL Gregersen PK STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus N Engl J Med 2007, 357:977-986. 10.1056/NEJMoa073003 17804842
31. Thomson W Barton A Ke X Eyre S Hinks A Bowes J Donn R Symmons D Hider S Bruce IN Wellcome Trust Case Control Consortium Wilson AG Marinou I Morgan A Emery P YEAR Consortium Carter A Steer S Hocking L Reid DM Wordsworth P Harrison P Strachan D Worthington J Rheumatoid arthritis association at 6q23 Nat Genet 2007, 39:1431-1433. 10.1038/ng.2007.32 17982455
32. Plenge RM Cotsapas C Davies L Price AL de Bakker PI Maller J Pe'er I Burtt NP Blumenstiel B DeFelice M Parkin M Barry R Winslow W Healy C Graham RR Neale BM Izmailova E Roubenoff R Parker AN Glass R Karlson EW Maher N Hafler DA Lee DM Seldin MF Remmers EF Lee AT Padyukov L Alfredsson L Coblyn J Weinblatt ME Gabriel SB Purcell S Klareskog L Gregersen PK Shadick NA Daly MJ Altshuler D Two independent alleles at 6q23 associated with risk of rheumatoid arthritis Nat Genet 2007, 39:1477-1482. 10.1038/ng.2007.27 17982456
33. Kochi Y Yamada R Suzuki A Harley JB Shirasawa S Sawada T Bae SC Tokuhiro S Chang X Sekine A Takahashi A Tsunoda T Ohnishi Y Kaufman KM Kang CP Kang C Otsubo S Yumura W Mimori A Koike T Nakamura Y Sasazuki T Yamamoto K A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities Nat Genet 2005, 37:478-485. 1362949 15838509 10.1038/ng1540
34. Ikari K Momohara S Nakamura T Hara M Yamanaka H Tomatsu T Kamatani N Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis Ann Rheum Dis 2006, 65:671-673. 10.1136/ard.2005.043489 16176992
35. Begovich AB Chang M Schrodi SJ Meta-analysis evidence of a differential risk of the FCRL3 -169T → C polymorphism in white and East Asian rheumatoid arthritis patients Arthritis Rheum 2007, 56:3168-3171. 10.1002/art.22857 17763442
36. Takata Y Inoue H Sato A Tsugawa K Miyatake K Hamada D Shinomiya F Nakano S Yasui N Tanahashi T Itakura M Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: Results of an independent Japanese population and evidence from meta-analysis of East Asian studies J Hum Genet 2007. 18087673
37. Eike MC Nordang GB Karlsen TH Boberg KM And The Ib MH Vatn Dahl-Jørgensen K Rønningen KS Joner G Flatø B Bergquist A Thorsby E Førre O Kvien TK Undlien DE Lie BA The FCRL3 -169T>Cpolymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritisin a Scandinavian panel of autoimmune diseases Ann Rheum Dis 2007. 18065500
38. Suzuki A Yamada R Chang X Tokuhiro S Sawada T Suzuki M Nagasaki M Nakayama-Hamada M Kawaida R Ono M Ohtsuki M Furukawa H Yoshino S Yukioka M Tohma S Matsubara T Wakitani S Teshima R Nishioka Y Sekine A Iida A Takahashi A Tsunoda T Nakamura Y Yamamoto K Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat Genet 2003, 34:395-402. 10.1038/ ng1206 12833157
39. Kang CP Lee HS Ju H Cho H Kang C Bae SC A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans Arthritis Rheum 2006, 54:90-96. 10.1002/art.21536 16385500
40. Hoppe B Haupl T Gruber R Kiesewetter H Burmester GR Salama A Dorner T Detailed analysis of the variability of pep-tidylarginine deiminase type 4 in German patients with rheumatoid arthritis: A case-control study Arthritis Res Ther 2006, 8:R34. 1526594 16469113 10.1186/ar1889
41. Verpoort KN van Gaalen FA van der Helm-van Mil AH Schreuder GM Breedveld FC Huizinga TW de Vries RR Toes RE Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis Arthritis Rheum 2005, 52:3058-3062. 10.1002/art.21302 16200610
42. Sigurdsson S Padyukov L Kurreeman FA Liljedahl U Wiman AC Alfredsson L Toes R Ronnelid J Klareskog L Huizinga TW Alm G Syvanen AC Ronnblom L Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis Arthritis Rheum 2007, 56:2202-2210. 10.1002/art.22704 17599733
43. Garnier S Dieude P Michou L Barbet S Tan A Lasbleiz S Bardin T Prum B Cornelis F IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis Ann Rheum Dis 2007, 66:828-831. 10.1136/ard.2006.061390 17158136
44. Rueda B Reddy MV González-Gay MA Balsa A Pascual-Salcedo D Petersson IF Eimon A Paira S Scherbarth HR Pons-Estel BA González-Escribano MF Alarcón-Riquelme ME Martín J Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis Arthritis Rheum 2006, 54:3815-3819. 10.1002/art.22271 17133578
45. van Oosterhout M Bajema I Levarht EW Toes RE Huizinga TW van Laar JM Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis Arthritis Rheum 2007, 58:53-60. 10.1002/art.23148
46. van der Helm-van Mil AH Kern M Gregersen PK Huizinga TW Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients Arthritis Rheum 2006, 54:2028-2030. 10.1002/art.21872 16732568
47. van der Helm-van Mil AH Huizinga TW Schreuder GM Breed-veld FC de Vries RR Toes RE An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility Arthritis Rheum 2005, 52:2637-2644. 10.1002/art.21272 16142711
48. Marinou I Healy J Mewar D Moore DJ Dickson MC Binks MH Montgomery DS Walters K Wilson AG Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status Arthritis Rheum 2007, 56:2549-2556. 10.1002/ art.22814 17665434
49. Prots I Skapenko A Wendler J Mattyasovszky S Yoné CL Spriewald B Burkhardt H Rau R Kalden JR Lipsky PE Schulze-Koops H Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis Arthritis Rheum 2006, 54:1491-1500. 10.1002/art.21832 16646030
50. Lard LR van Gaalen FA Schonkeren JJ Pieterman EJ Stoeken G Vos K Nelissen RG Westendorp RG Hoeben RC Breedveld FC Toes RE Huizinga TW Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis Arthritis Rheum 2003, 48:1841-1848. 10.1002/art.11160 12847677
51. Mattey DL Nixon NB Dawes PT Ollier WE Hajeer AH Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis Genes Immun 2004, 5:147-149. 10.1038/sj.gene.6364050 14712311
52. Dörr S Lechtenböhmer N Rau R Herborn G Wagner U Müller-Myhsok B Hansmann I Keyszer G Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis Arthritis Res Ther 2004, 6:R199-R207. 416441 15142265 10.1186/ar1164
53. Constantin A Lauwers-Cances V Navaux F Abbal M van Meer-wijk J Mazieres B Cambon-Thomsen A Cantagrel A Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study Arthritis Rheum 2002, 46:1754-1762. 10.1002/art.10336 12124858
54. van der Kooij SM de Vries-Bouwstra JK Goekoop-Ruiterman YP vanZeben D Kerstens PJ Gerards AH van Groenendael JH Hazes JM Breedveld FC Allaart CF Dijkmans BA Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent-onset rheumatoid arthritis treated according to the Disease Activity Score Ann Rheum Dis 2007.
55. de Vries-Bouwstra J Le Cessie S Allaart C Breedveld F Huizinga T Using predicted disease outcome to provide differentiated treatment of early rheumatoid arthritis J Rheumatol 2006, 33:1747-1753. 16845710